CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 528 shares at $28.04 ($14,803)
- 4 Open-market sale SVP, Global Controller sold 2,500 shares at $32.40 ($81,000)
- 4 Grant or award Head of Research & Development acquired 527 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 434 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 218 shares (grant or award)
- 4 Open-market buy Director bought 2,910 shares at $28.30 ($82,353)
- 4 Open-market buy Director bought 2,625 shares at $31.02 ($81,425)
- 4 Open-market sale Director sold 14,608 shares at $32.00 ($467,456)
- 4 Open-market buy Director bought 8,437 shares at an average $30.44 ($256,791)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $29.65 ($296,492)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 147,991 shares at $26.25 ($3,884,764)
- 4 Open-market sale SVP, Global Controller sold 3,459 shares at $26.23 ($90,743)
- 4 Open-market sale Chief Operating Officer sold 1,425 shares at $25.65 ($36,546)
- 4 Open-market sale Chief Development Officer sold 1,004 shares at $25.65 ($25,749)
- 4 Open-market sale Head of Research & Development sold 1,425 shares at $25.65 ($36,546)
- 4 Open-market sale SVP, Global Controller sold 915 shares at $25.65 ($23,467)
- 4 Open-market sale President and CEO sold 5,498 shares at $25.65 ($141,005)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
- 4 Other disposition 10% owner disposed of 2,030,000 shares (other)
Page 9 of 18 · 356 filings